Marble Harbor Investment Counsel LLC Sells 2,100 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Marble Harbor Investment Counsel LLC reduced its position in shares of Stericycle, Inc. (NASDAQ:SRCLFree Report) by 2.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 98,962 shares of the business services provider’s stock after selling 2,100 shares during the period. Marble Harbor Investment Counsel LLC’s holdings in Stericycle were worth $5,753,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Pentwater Capital Management LP purchased a new position in shares of Stericycle during the second quarter valued at approximately $83,010,000. Capital Research Global Investors raised its stake in Stericycle by 13.4% in the fourth quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider’s stock worth $296,762,000 after buying an additional 705,586 shares in the last quarter. Nuance Investments LLC purchased a new stake in Stericycle in the second quarter worth about $37,263,000. American Century Companies Inc. bought a new stake in Stericycle during the 2nd quarter valued at approximately $34,760,000. Finally, Sei Investments Co. grew its holdings in shares of Stericycle by 35.5% during the 4th quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider’s stock worth $52,601,000 after acquiring an additional 277,896 shares during the period. 98.82% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on SRCL. Truist Financial lifted their price target on Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research report on Tuesday, June 4th. StockNews.com initiated coverage on shares of Stericycle in a research report on Monday, September 9th. They issued a “hold” rating on the stock. Royal Bank of Canada reissued a “sector perform” rating and set a $62.00 price target (down from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Finally, Keefe, Bruyette & Woods upped their price objective on shares of Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a report on Tuesday, June 4th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Stericycle presently has a consensus rating of “Hold” and a consensus price target of $74.00.

Read Our Latest Stock Report on Stericycle

Stericycle Stock Performance

Shares of SRCL stock opened at $61.71 on Monday. The company has a market capitalization of $5.73 billion, a price-to-earnings ratio of -280.50, a price-to-earnings-growth ratio of 3.37 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13. Stericycle, Inc. has a one year low of $37.78 and a one year high of $61.77. The company’s 50-day moving average is $59.00 and its 200 day moving average is $54.57.

Stericycle (NASDAQ:SRCLGet Free Report) last issued its earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.57 by $0.04. The firm had revenue of $661.60 million for the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. Sell-side analysts expect that Stericycle, Inc. will post 2.29 EPS for the current fiscal year.

Stericycle Company Profile

(Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

Read More

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCLFree Report).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.